Navigation Links
Data show a decline in cystic fibrosis since introduction of prenatal carrier screening
Date:2/27/2008

A brief report in the February 28, 2008, New England Journal of Medicine, led by researchers at the New England Newborn Screening Program (NENSP) of the University of Massachusetts Medical School (UMMS), indicates a declining incidence of a genetic disease, providing what may be the first demonstration of a link between two independent population-based screening programs.

The state of Massachusetts has offered universal newborn screening to detect cystic fibrosis (CF) since 1999. Independently, recommendations for nationwide (adult) carrier screening for CF were introduced in the U.S. around 2002, coming from the National Institutes of Health, the American College of Obstetrics and Gynecology and the American College of Medical Genetics. Newborn screening for cystic fibrosis (much like newborn screening for other conditions), a public health service geared toward improving the lives of babies born with treatable conditions, identifies infants across the state who are at risk for disease and ensures that these infants are referred for diagnostic evaluation and (when appropriate) care. Tracking the number of infants who are diagnosed with the disease is an integral part of quality assurance of the newborn screening program.

Using the Massachusetts newborn screening data, the researchers compared two four-year periods: 1999 to 2002, just before prenatal CF carrier screening came into wide practice, and 2003 to 2006.

The number of live-born infants with CF dropped by about 50 percent from one four-year period to the next. Moreover, among the babies who were born with CF, markedly fewer had two copies of the delta F508 gene mutation, associated with a severe form of CF. The authors, who work closely with the clinician directors of the five Massachusetts CF Centers at Baystate Medical Center in Springfield; Childrens Hospital Boston; Massachusetts General Hospital; New England Medical Center; UMass Memorial Health Care in Worcester;
'/>"/>

Contact: Mark Shelton
mark.shelton@umassmed.edu
508-856-2000
University of Massachusetts Medical School
Source:Eurekalert

Page: 1 2

Related biology technology :

1. Entry of Biogenerics and Decreasing Use of Amgens Epogen and Johnson & Johnsons Procrit Will Cause a $2.8 Billion Decline in the Drug Market for Chemotherapy-Induced Anemia by 2016
2. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
3. GeneGo and the Cystic Fibrosis Foundation Collaborate to Advance Understanding of Cystic Fibrosis
4. PTC Therapeutics Announces Encouraging Additional Phase 2 Results of PTC124 in Cystic Fibrosis
5. Cystic Fibrosis: License Agreement Boosts Development of Therapy Against Lung Infections
6. Medical Breakthrough ... Doctor Discovers Penetrating Carrier That Eradicates Fungus
7. NeoMatrix Announces Additional Funding for Breakthrough Breast Cancer Screening Test
8. BioReliance Launches Next-Generation Genotoxicity Screening Service
9. Diamics Receives European CE Mark Approval for Its Pap-Map(TM) System for Cervical Cancer Screening
10. Enigma Diagnostics to Develop Clinical Diagnostics Platform for UK National Chlamydia Screening Programme
11. Swiss Experts Recommend QuantiFERON(R)-TB Gold for Tuberculosis Infection Screening Prior to Initiating anti-TNF-a Therapy

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... , LELYSTAD, The Netherlands, December 2 /... based biotechnology company focusing on protein m...herapeutics today announced that it,has appointed .... , Dr. Mol will be responsible for all o...agement and strategic direction of the company. He...
(Date:12/2/2009)... , RESTON, Va., Dec. 2 /PRNewswire-Asia-... or the "Company") (OTC Bulletin Board: EMDY), a l...dren,s formula, milk powder and,soybean products i...featured,in the Spring issue of US Food & Drin...p of over 250,000 executives in the food and bever...
(Date:12/2/2009)... The Scientist, a leading scien...Photometrics’ Evolve “Intelligent&rdqu...;s “Top 10 Innovations of 2009. , ...olve ™ EMCCD camera from Photometrics ®... CCD and EMCCD cameras for the life sciences, was ...
(Date:12/1/2009)... , NEW YORK, Dec. 1 Repor...eport is available in its catalogue: ,, Chrom...ortlinker.com/p0164494/Chromium---Global-Market-Tr...primarily influenced by stainless steel, while gro...s is also important for growth of chromium metal. ...
Breaking Biology Technology:Dutch Biotech Company Pepscan Appoints New CEO 2Emerald Dairy To Be Featured in Spring Issue of US Food and Drink Executive 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3Reportlinker Adds Chromium - Global Market Trends 2Reportlinker Adds Chromium - Global Market Trends 3Reportlinker Adds Chromium - Global Market Trends 4Reportlinker Adds Chromium - Global Market Trends 5Reportlinker Adds Chromium - Global Market Trends 6Reportlinker Adds Chromium - Global Market Trends 7Reportlinker Adds Chromium - Global Market Trends 8Reportlinker Adds Chromium - Global Market Trends 9
...rmaceuticals, Inc. (Nasdaq: TPPH ) announced toda...ovember 5, 2007 at 12:00 p.m. Eastern Time,(10:00 ...quarter 2007,financial results and provide a compa...regarding its second quarter financial results on ...rticipate in the conference call, please dial 800-...
...y of Pediatrics National Conference & ...AST NORRITON, Pa., Oct. 29 Tengion,Inc., a leader...ndings from,a preclinical study being presented to...tional Conference and Exhibition demonstrate the a...estore bladder function in a,well- established pre...
...unced today that it,has received the European CE M...p(TM) System for cervical cancer screening. The CE..., safety and environmental requirements,that ensur...therlands, the,registration will allow the system ...r countries around the world that recognize the CE...
Other Biology Technology:Tapestry to Host Conference Call on November 5th to Discuss Third Quarter 2007 Financial Results 2Preclinical Efficacy Data Demonstrate Ability of Tengion's Neo-Bladder Augment to Restore Bladder Function 2Preclinical Efficacy Data Demonstrate Ability of Tengion's Neo-Bladder Augment to Restore Bladder Function 3Diamics Receives European CE Mark Approval for Its Pap-Map(TM) System for Cervical Cancer Screening 2
(Date:12/2/2009)...N - A team comprised of undergraduate students fro...honors in a national poster contest hosted by the ...ng (ISPE). , The annual contest highlights the r...t month at the ISPE Annual Meeting in San Diego, C...f a Posterior Criciate Ligament Tensioning Device,...
(Date:12/2/2009)...w study on the smokeless tobacco product called mo...entists in Minnesota to urge the tobacco industry ...s content of carcinogens. Their study is published... in Toxicology . It reports that this category of ... of certain toxic and cancer-causing substances. C...
(Date:12/2/2009)...le-walled nanotubescylinders of carbon about a nan...ntial applications such as ultrastrong fibers, ele...orage components for fuel cells. Thanks to a new d...e of Standards and Technology (NIST) and five part...: detection and destruction of an aggressive form ...
Breaking Biology News(10 mins):Combining nanotubes and antibodies for breast cancer 'search and destroy' missions 2Reconstructive Plastic Surgery Patients Honored for Giving Back 59589 1Reconstructive Plastic Surgery Patients Honored for Giving Back 59589 2Reconstructive Plastic Surgery Patients Honored for Giving Back 59589 3Reconstructive Plastic Surgery Patients Honored for Giving Back 59589 4Video 3A Cities and States Around the U S Recognize October 13 as Metastatic Breast Cancer Awareness Day 59586 1Video 3A Cities and States Around the U S Recognize October 13 as Metastatic Breast Cancer Awareness Day 59586 2Video 3A Cities and States Around the U S Recognize October 13 as Metastatic Breast Cancer Awareness Day 59586 3Micro Waste Corporation Ordered to Pay Sanitecs Attorney Fees 59583 1Micro Waste Corporation Ordered to Pay Sanitecs Attorney Fees 59583 2
...n that seems to be pivotal in lifting depression h...funded by the National Institutes of Health,s Nati...eficient in this protein, called p11, display depr... amounts behave as if they have been treated with ... a Rockefeller University neuroscientist who recei...
...ledge that one disease may prevent the onset of an...cowpox vaccines can prevent smallpox dates back to...iatrics at the Mattel Children,s Hospital at UCLA,... ways that one disease prevents another. , His fi...lic influences should be considered when looking f...
...ts have discovered that a stem cell factor overexp...llowing brain injury promotes tumor survival by in... in the April issue of Cancer Cell, examines the i...sues and may have substantial significance for des...most lethal types of tumor, malignant gliomas. , ...
Other Biology News:Nobelist discovers antidepressant protein in mouse brain 2Nobelist discovers antidepressant protein in mouse brain 3UCLA paper examines how one disease may prevent another 2Growth factor-promoting angiogenesis expressed in tumor cells and normal neurons 2
Mouse Anti-p230 trans Golgi Monoclonal Antibody, Unconjugated, Clone 15 from BD Biosciences Pharmingen
... fluorescent and highly photostable FluoSpheres mi...riety of applications requiring probes that can de... other macromolecule-labeled microspheres have hyd...n-target surfaces in some applications. This nonsp...
DNA Polymerase I Large (Klenow) Fragment from Invitrogen
... Description: Proteinase K is a highly active a...plications purified from the fungus T. album. It c... group of N-substituted hydrophobic aliphatic and ...erine protease. Proteinase K is useful in purifyin...
Biology Products: